Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Receivables - Net: 2021-2024

Historic Receivables - Net for Keros Therapeutics (KROS) over the last 3 years, with Dec 2024 value amounting to $2.7 million.

  • Keros Therapeutics' Receivables - Net rose 800.00% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 800.00%. This contributed to the annual value of $2.7 million for FY2024, which is 1817.48% up from last year.
  • As of FY2024, Keros Therapeutics' Receivables - Net stood at $2.7 million, which was up 1,817.48% from $143,000 recorded in FY2023.
  • Over the past 5 years, Keros Therapeutics' Receivables - Net peaked at $18.0 million during FY2021, and registered a low of $143,000 during FY2023.
  • Over the past 2 years, Keros Therapeutics' median Receivables - Net value was $1.4 million (recorded in 2023), while the average stood at $1.4 million.
  • Data for Keros Therapeutics' Receivables - Net shows a peak YoY spiked of 1,817.48% (in 2024) over the last 5 years.
  • Keros Therapeutics' Receivables - Net (Yearly) stood at $18.0 million in 2021, then reached $143,000 in 2023, then spiked by 1,817.48% to $2.7 million in 2024.